This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas.
"synopsis" may belong to another edition of this title.
From the reviews:
"...warmly recommend this book as a comprehensive, up-to-date, and detailed yet concise source of information about AML." -The New England Journal of Medicine
"Acute Myelogenous Leukemia, edited by Judith E. Karp, MD, of Johns Hopkins University, is a multiauthored textbook directed towards the hematologist managing acute leukemia ... . It focuses on new approaches, both practical and theoretical, based on laboratory data as well as clinical studies. ... This textbook includes up-to-date, well-referenced chapters ... . It is a welcomed edition to provide specific information and reference data for hematologists who specialize in AML management." (Barry Cooper, Baylor University Medical Center Proceedings, Vol. 21 (1), 2008)
"The book begins with an overview of the disease and ends with a chapter on some of the particular challenges faced by clinicians ... . For clinicians involved in investigation of new agents, there is considerable usefulness ... . In Acute Myelogenous Leukemia, the reader will find reviews of some of the newer agents and treatment strategies for this uncommon but devastating disease. In addition, this is a reliable source for thorough and clearly written explanations of the scientific development of these new agents." (Laura C. Michaelis, Journal of the American Medical Association, November, 2007)
"About this title" may belong to another edition of this title.
Book Description Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT23-144904
Book Description Condition: New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery.This item may ship from the US or other locations in India depending on your location and availability. Seller Inventory # ABTR-65862
Book Description Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. This item may ship from the US or our Overseas warehouse depending on your location and stock availability. We Ship to PO BOX Location also. Seller Inventory # ABRR-65862
Book Description Condition: New. New. In shrink wrap. Looks like an interesting title! 2.4. Seller Inventory # Q-1588296210
Book Description Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT23-144905
Book Description Condition: New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery.This item may ship from the US or other locations in India depending on your location and availability. Seller Inventory # ABTR-215909
Book Description Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. This item may ship from the US or our Overseas warehouse depending on your location and stock availability. We Ship to PO BOX Location also. Seller Inventory # ABRR-215909
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Novel therapeutic concepts based on AML cell biologyCritical factors in leukemia cell survival and drug resistance, and their potential exploitation as therapeutic targetsThis is a timely compilation of new concepts in the molecular pat. Seller Inventory # 4221627
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas. 452 pp. Englisch. Seller Inventory # 9781588296214
Book Description Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Acute Myelogenous Leukemia is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. Bringing together new concepts and findings in the basic and clinical science of AML, the book emphasizes the molecular basis for new therapies that stand to have the greatest potential impact on the clinical face of these diseases. The text provides insights into selected novel strategies currently and prospectively being developed, including interruption of specific signal transduction pathways, modulation of gene expression, attempts to reinstate differentiation, and immunomodulation. There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas, and both basic and clinical scientists will benefit from this translational text. Seller Inventory # 9781588296214